Table 5.
Compound no | Compound name | Lipinski | BBB | HIA | PGP- | Bioavailability score |
---|---|---|---|---|---|---|
1 | Ergost-25-ene-3,6-dione, 5,12-dihydroxy-, (5.alpha.,12.beta.)- | Yes | No | High | No | 0.55 |
2 | Aspidospermidin-17-Ol, 1-Acetyl-16-Methoxy- | Yes | Yes | High | Yes | 0.55 |
3 | 2-[3,4-Dichlorophenyl]-4-[[2-[1-methyl-2-pyrrolidinyl]ethyl]amino]-6-[trichloromethyl]-S-triazine | Yes | Yes | High | Yes | 0.55 |
4 | Dihydroartemisinin, 10-O-(t-butyloxy)- | Yes | Yes | High | Yes | 0.55 |
5 | 3-[(2-fluoroanilino)methyl]-5-(2-methoxyphenyl)-1,3,4-oxadiazole-2(3 h)-thione | Yes | No | High | Yes | 0.55 |
6 | 2(1H)-naphthalenone, 5-[2-(3-furanyl)ethyl]octahydro-1,5,6,8a-tetramethyl-, | Yes | Yes | High | Yes | 0.55 |
7 | 4H-1-benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-7-methoxy- | Yes | No | High | Yes | 0.55 |
8 | 2-butenoic acid, 2-methyl-, 4,4a,5,6,7,8,8a,9-octahydro-8a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-6-yl ester | Yes | Yes | High | Yes | 0.55 |
9 | Benzonitrile, 4-(4-ethylcyclohexyl)-, trans- | Yes | Yes | High | Yes | 0.55 |
10 | 1-(2-adamantylidene) semicarbazide | Yes | Yes | High | No | 0.55 |
11 |
Doxorubicin (synthetic drug) |
No | No | Low | NA | 0.17 |